Global Joint Pain Injections Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2028

"Global Joint Pain Injections Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global joint pain injections market report has been segmented on basis of injection type, joint type, end-user, and region

Global Joint Pain Injections Market: Overview

Joints are places in the body where bones are connected, and most joints allow for movement and flexibility. A joint pain injection is a minimally invasive procedure can help for temporarily relieve of pain caused by an inflamed joint. Any damage to a joint from injury or disease interfere with the mobility and may result in pain and inflammation. The generally joint pain experienced by most of the population includes hips, knees, shoulders, and joints in the hand and wrist joint pain.

Global Joint Pain Injections Market: Dynamics

Increasing prevalence and incidences of knee related disorders is a key factor expected to drive growth revenue of the target market. In addition, rising healthcare expenditure, growing demand for good quality of healthcare, increasing geriatric population are among some of the other major factors expected to drive growth of the global market. Furthermore, increasing number of cases of shoulder pain owing to high usage of gadgets such as mobiles, PCs and laptops among the general population and rising demand for more effective than an oral medication are among the other factors expected to support growth of the global market over next ten years.

However, one of the key restraints to growth of the market are the lack or low awareness related to health among a large section of the overall population and stringent regulations.

Global Joint Pain Injections Market: Trends

Major players in the target market are focusing on launching new technologically advent product in the global market in order to cater the growing incidences of osteoarthritis and other joints related disorders and diseases, as well as are directing towards receiving regulatory authorities’ approvals are the key trends currently witnessed in the global market.

In October 2017, Flexion Therapeutics, Inc. received US FDA approves new injection Zilretta for osteoarthritis

Global Joint Pain Injections Market: Segment Analysis

Among the joint type segments, the knee & ankle segment is expected to maintain a dominant position and register highest revenue growth rate as compared to other joint type segments. This is attributed to growing elderly population especially in developing regions. The end use segment is further segmented into hospital pharmacies, retail pharmacies, and online pharmacies wherein the hospital pharmacies currently account for largest revenue share in the target market.

Global Joint Pain Injections Market: Region Analysis

The market in North America is projected to account for major revenue share in the global market, followed by the market in Europe. This is primarily attributed to, favourable reimbursement policies as well as increasing geriatric population base in countries in this region. Revenue from the Asia Pacific Joint Pain Injections market is anticipated to grow at a high CAGR over upcoming years, owing to the increased awareness about joint pain in developing countries, such as India in the region.

Global Joint Pain Injections Market Segmentation

Segmentation by Injection type:

• Corticosteroid Injections
• Hyaluronic Acid Injections
• Others (include, Platelet-rich plasma (PRP), Placental tissue matrix (PTM), etc.)

Segmentation by joint type:

• Knee & Ankle
• Hip Joint
• Shoulder & Elbow
• Facet Joints of the Spine
• Others (include, Ball and socket, etc.)

Segmentation by end-user:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Segmentation by Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Allergan Plc.
• Pfizer Inc.
• Sanofi
• Anika Therapeutics, Inc.
• Ferring B.V.
• Bioventus LLC
• Flexion Therapeutics, Inc.
• Zimmer Biomet Holdings, Inc.
• Seikagaku Corporation
• Chugai Pharmaceutical Co., Ltd.